Medea Biopharma GmbH, a German biotech company based in Ludwigshafen, Germany, was co-founded by Rüdiger Trojok, Dr. Elene Kakabadze, and Giorgi Khubua. Medea Biopharma GmbH specializes in the development of a new generation of sustainable and eco-friendly antibacterial solutions based on bacteriophages (phages), designed to solve the global crisis of antimicrobial resistance. Phages are natural bacterial killers, which are highly specific and without side effects. These innovative alternatives aim to replace conventional chemical antibiotics, copper-based solutions, and harmful pesticides, offering effective and environmentally responsible ways to combat harmful bacteria across diverse sectors, including human health, animal well-being, and agriculture.
Company Details
- Employees
- 10
- Founded
- -
- Address
- Donnersbergweg 1, Ludwigshafen,rhineland-Palatinate 67059,germany
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.medea-bio.com
- Keywords
- Tolka AI Therapeutics.
- HQ
- Ludwigshafen, Rhineland-Palatinate
Medea Biopharma Questions
Medea Biopharma's website is http://www.medea-bio.com
Medea Biopharma's LinkedIn profile is https://de.linkedin.com/company/medea-biopharma
Medea Biopharma has
10 employees.
View email and phone details for 10
employees at Medea Biopharma.
Medea Biopharma's industry is
Biotechnology Research
Medea Biopharma's top competitors are
Caesar.,
Tolka Ai Therapeutics,
Phage Australia,
Phagos,
Onmatter,
Merall Bioproducts Gmbh,
Phagelab,
Eligo Bioscience,
Zamann Pharma Support,
Streavent.
Medea Biopharma's categories are Biotechnology Research
Medea Biopharma's founding year is 2023
